We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA to FDA: Let Industry Self-Regulate Trial Transparency
PhRMA to FDA: Let Industry Self-Regulate Trial Transparency
October 10, 2013
The drug industry is in the best position to decide how to make preclinical and clinical trial data more widely available, according to PhRMA.